HCA said the repurchase program has no time limit and may be discontinued at anytime.
Including this program and remaining amounts under the $3 billion share repurchase plan unveiled in October 2015, HCA has about $2.04 billion authorized for share repurchases.
More articles on healthcare finance:
Allina Health’s bottom line takes $104.8M hit from nurse strikes
8 hospitals receive credit downgrades in past month
Patients hit with surprise bills for 22% of in-network ER visits
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
